Analysis of Prognostic Factors of 80 Advanced NSCLC Patients Treated with Gefitinib for more than 6 Months

Analysis of Prognostic Factors of 80 Advanced NSCLC Patients Treated with Gefitinib for more than 6 Months

Background and objective Some clinical predictors can be used to evaluate the efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for non-small cell lung cancer (NSCLC), including female, East-Asian, non-smoker, adenocarcinoma, skin rash, etc. The aim of this st...

Full description

Bibliographic Details
Main Authors: Ling DAI, Jian FANG, Jun NIE, Weiheng HU, Xiaoling CHEN, Jindi HAN, Guangming TIAN, Sen HAN, Xuyi LIU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2010-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Gefitinib
Targeted therapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.10

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.10

Similar Items